We examined the basal levels of KRT13 expression in developing human prostate and in three lineage-related isogenic prostate cancer bone metastatic progression cell models, and validated KRT13 expression in an aggressive and metastatic CWR22Rv1 model. The gene discussed is KRT13; the disease is prostate cancer.